Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts
Por um escritor misterioso
Descrição
Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]
PDF) Efficacy and safety of upadacitinib in patients with
Full article: POSTER PRESENTATIONS
Full article: ABSTRACTS OF THE 38TH SCANDINAVIAN CONGRESS OF
ACR Convergence 2022
The Ankylosing Spondylitis Disease Activity Score (ASDAS) is the
Canadian Rheumatology Association Meeting Quebec City Convention
Impact of tapering targeted therapies (bDMARDs or JAKis) on the
PDF) Effectiveness and safety of adalimumab in patients with
Dual neutralisation of interleukin-17A and interleukin-17F with
Effect of body mass index on treatment response of biologic
JPM, Free Full-Text
Efficacy and Safety of Tofacitinib in Patients with Ankylosing
744, PDF, Rheumatoid Arthritis
Impact of Achieving ASDAS LDA on Disease Activity and Patient
Impact of Achieving ASDAS LDA on Disease Activity and Patient
de
por adulto (o preço varia de acordo com o tamanho do grupo)
